Page last updated: 2024-11-02

pioglitazone and Candidemia

pioglitazone has been researched along with Candidemia in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Candidemia: A form of invasive candidiasis where species of CANDIDA are present in the blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Majer, O1
Bourgeois, C1
Zwolanek, F1
Lassnig, C1
Kerjaschki, D1
Mack, M1
Müller, M1
Kuchler, K1

Other Studies

1 other study available for pioglitazone and Candidemia

ArticleYear
Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections.
    PLoS pathogens, 2012, Volume: 8, Issue:7

    Topics: Animals; Antigens, CD; Antigens, Ly; Candida albicans; Candidemia; Candidiasis; Chemokine CCL2; Chem

2012